Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

INMBINMB
Showing 5 of 20 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in INMUNE BIO INC

CITADEL ADVISORS LLC holds 106,231 shares of INMB (INMUNE BIO INC), worth $173,157 as of 2026-Q2. This is a new position.

Current Value

$173,157

Current Shares

106,231

Total Value Change

-$75,408

Total Shares Change

+60,115

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
106,231
-
$173,1570.0%$1.63
35
2025-Q2
Exited
0
-100.0%
$00.0%$5.33
0
2025-Q1
Increased
101,511
+94.5%
$792,8010.0%$7.52
39
2024-Q4
Increased
52,197
+13.2%
$243,7600.0%$4.65
18
2024-Q3
Increased
46,116
+50.3%
$248,5650.0%$5.22
22

Other major holders of INMB: BlackRock, Inc., BlackRock Finance, Inc., VANGUARD GROUP INC, Steward Partners Investment Advisory, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used